Sedana Medical AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 37.78 million compared to SEK 33.65 million a year ago. Net loss was SEK 16.12 million compared to SEK 18.97 million a year ago.

Basic loss per share from continuing operations was SEK 0.16 compared to SEK 0.19 a year ago. Diluted loss per share from continuing operations was SEK 0.16 compared to SEK 0.19 a year ago.